Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GEN-310
- Development stage
- Preclinical
- Lead developer
- GenVivo
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies, Lymphokine-Activated Killer Cells → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies, Gene Therapies
- Administration
- Intravenous
01
Overview
GEN-310 is an investigational in vivo gene therapy developed by GenVivo for the treatment of B-cell malignancies. The therapy utilizes a viral vector platform designed to reprogram a patient's endogenous T cells and natural killer (NK) cells directly within the body to express chimeric antigen receptors (CARs). This in vivo approach aims to circumvent the logistical challenges, high costs, and lengthy manufacturing times associated with traditional ex vivo CAR-T cell production. By transforming immune cells in situ, GEN-310 seeks to generate a sustained therapeutic population of CAR-expressing cells to target and eliminate malignant B cells. As of late 2025, GEN-310 is in the IND-enabling and preclinical stages of development.
Beyond the preview
Go deeper on GEN-310.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GEN-310.